Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
105.25 USD | +1.12% |
|
+9.48% | +13.94% |
02-18 | Cantor Fitzgerald Adjusts Gilead Sciences Price Target to $100 From $80, Maintains Neutral Rating | MT |
02-18 | DBS Bank Adjusts Gilead Sciences Price Target to $125 From $100 | MT |
ETFs positioned on Gilead Sciences, Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.99% | 248 M€ | -3.63% | - | |
3.55% | 1 M€ | 0.00% | - | |
2.9% | 493 M€ | +3.86% | ||
2.66% | 33 M€ | +3.72% | - | |
2.62% | 427 M€ | -0.45% | ||
2.58% | 6 M€ | 0.00% | - | |
2.27% | 3 M€ | -.--% | ||
1.96% | 0 M€ | -.--% | - | |
1.26% | 7 M€ | -.--% | ||
1.16% | 128 M€ | +4.01% | ||
1.04% | 748 M€ | +4.52% | ||
1.01% | 1,262 M€ | +9.15% | ||
0.98% | 5 M€ | -22.24% | - | |
0.98% | 1 M€ | -.--% | - | |
0.92% | 13 M€ | +5.45% |

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GILD Stock
- ETFs Gilead Sciences, Inc.

MarketScreener is also available in this country: United States.
Switch edition